Who are we?
Investors & financial institutions
- Independent credit research
  - High Yield credit research
  - Index sponsor
- ESG Solutions
- Consulting
- Our services for Investors & financial institutions
  - EthiFinance is an independent European rating, research and advisory company, operating in both the financial and non-financial fields. The Group offers a full range of services to Investors and Financial institutions through its four complementary business units. Its solutions address all financial players: institutional investors, asset managers, banks, insurance companies, etc.
Corporates & organisations
- ESG solutions
- Consulting
- Practices
  - Taxonomy
  - Biodiversity analysis
- Our services for corporates & organisations
  - EthiFinance is an independent European rating, research and advisory company, operating in both the financial and non-financial fields. The Group offers a full range of services to Corporates and Organisations through its three complementary business units. Its solutions address both companies and local governments.
Credit rating agency
- About ratings
- Product & services
- Regulatory
- Notifications & events
  
  Notifications
  
  Publications
  
  News
  Login
Insights
News
|
- FR
- ES
Language
- - |
    
    French
  - |
    
    Spanish

IZERTIS SA

Type of ratings: Corporate

Rating value: BB+

Outlook: Stable

License: EthiFinance Ratings

Solicited

Izertis, S.A., founded in 1996, and its subsidiaries (hereinafter Izertis,'the company' or 'the group') operates in the technology consulting sector with the aim of facilitating the digital transformation of companies. The group has offices in nine countries, with projects in more than 50. For 2022 the company reported revenues of € 88.4m (+36.0% YoY) with EBITDA of € 12.1m (EBITDA margin of 13.6%) and an adjusted NFD/EBITDA ratio of 3.2x. First-half 2023, revenues amounted to € 57.8m (+45.5% vs. 1H22) with EBITDA of € 9.0m (EBITDA margin of 15.6%) and an adjusted NFD/EBITDA ratio of 3.5x. The group has been listed on Spain's BME Growth since November 2019, with a market capitalization of € 208.8m as of 05/10/2023.

Ratings

Rating action: Upgrade

Action date: 2023-10-18

Date last rating: 2023-10-18

Date first rating: 2020-12-30

Documents

Executive summary:

Methodology

Corporate Rating Methodology

Return to the rating page